Wednesday, December 20, 2006

Rituxan receives FDA warning

The FDA issued a warning for those taking Rituxan. Rituxan is a biologic response modifier that is approved for people with non-Hodgkins lymphoma and Rheumatoid arthritis. The warning comes after 2 deaths and 23 cases of progressive multifocal leukoencephalopathy (PML), a viral brain infection.

First Celebrex et al.. now this. I don't take this drug, but I know that this must be disheartening to those who are. Adding new "side effects" to your drug cocktail is never pleasant.